Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

Raymond Osarogiagbon, MD, highlights the potential benefits of increasing screening rates for patients diagnosed with lung cancer and the broader US health care system.

Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent Post-TB Lung Disease, Study Suggests Apr. 21, 2025 — An experimental drug now in clinical trials as a cancer ...

If you have questions about Opdivo for squamous cell lung cancer treatment, talk with your doctor. Is Opdivo approved to treat stage 4 lung cancer? Yes, in certain situations. Stage 4 lung cancer ...

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Q1 2025 Management View Executive Chairman Bill Doyle highlighted the company’s transition to a multi-indication oncology company, emphasizing the regulatory and commercial advancements. He announced ...

Shares of NovoCure ( NVCR 0.43%) are edging higher on Thursday. The company's stock gained 0.11% as of 3:30 p.m. ET after ...

Scientists at Ankara University (AU) have developed an artificial intelligence-supported application that could enable the ...